Hello, In regards to the Regulatory Notice issued by the Financial Industry Regulatory Authority (FINRA) on March 8, 2022, I would like to express my concern as to the potential limits this rule will impose on some investors for buying and selling of the leveraged and inverse funds or other products deemed to be complex in nature. I regularly use these products as a focal point of my trading
I am deeply disturbed by the proposed regulation limiting access to leveraged and inverse ETFs (which are publicly-traded securities) to those with high net worth who pass a specialized regulatory exam and then jump through a series of administrative and timing-related hoops.
Leveraged and inverse ETFs are one of the few methods that the little guy has in order to protect his or her investments
Thank you for the opportunity to comment.
I am an informed investor. I have a plan in place to be able to maximize retirement moneys. I have used a leveraged fund for several years (TQQQ).
The nature of TQQQ is volatile. I clearly understand the volatile nature. I depend on the volatile nature of this fund as if gives best opportunity for growth.
I oppose the proposed regulation. In this
Hi, I am writing to ask you to NOT limit my ability to freely invest in any type of public securities. I'm an individual investor and I've been investing and trading securities of all kinds for the past 10 years. Im an active learner and constantly educate myself about opportunities and associated risks. I have paid-subscriptions to several investment advisors. I make informed decisions
Regarding L&I funds and potentially restricting access to them... I would oppose any such move.
Firstly, my current brokers (TDAmeritrade, E*Trade Financial, and Charles Schwab & Co, Inc) all provide me with ample educational materials online at no charge which informs me of the risks and limitations involved in trading L&I products, namely, they are intended
New Rate for Fees Paid Under Section 31 of the Exchange Act
This is great and all along with all the new regulations by the SEC, DTCC, FINRA, etc. However, these regulations are toothless in nature and are either not enforced by regulators who look the other way or they impose a very minimal fine that does not affect the institutions violating the law. There are a set of rules for the retail investor then there is a set of rules for market makers and
On my journey to investing in the stock market and am finding out that groups of Hedge funds have been manipulating stocks for their own and client’s personal gain. Where shorting a stock can be useful to help companies provide liquidity and entice investors, shorting companies to bankruptcy is not. In fact to bankrupt a company in order to make naked shorts disappear (and hence any
FINRA publishes this quarterly review to provide firms with a summary sampling of recent disciplinary actions involving misconduct by registered representatives. The sample includes settled matters and decisions in litigated cases (National Adjudicatory Council decisions and decisions of the SEC in FINRA cases). These summaries call attention to, and remind registered representatives and firms of, specific conduct that violates FINRA rules and may result in disciplinary action.
Regulatory Notice 13-10 announced the SEC’s approval, pursuant to FINRA Rule 4524, of the Derivatives and Other Off-Balance Sheet Items Schedule (OBS) as a supplement to the FOCUS report. At the time of its adoption, the OBS required all firms that carry customer accounts or self-clear or clear transactions for others (collectively, “carrying or clearing firms”) to file with FINRA the
